Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of LAMIGRASE vs Dovato under fasting conditions in healthy adults
TCTR20241122005Phase 1Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dolutegravir + lamivudine (2 arms), sponsored by Government Pharmaceutical Organization. Started Jan 2025; status: completed.
02
Drugs
dolutegravir + lamivudine
Beyond the preview
Go deeper on TCTR20241122005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241122005.